Creative Biolabs-Immuno-oncology

Anti-MUC16 (clone K8LL7) SynExpress C-mSc-I17-P Modified CD8+ T cells (CAT#: ITS-1224-CR1268)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target MUC16 (clone K8LL7). We employs the HBV (CMV-mScarlet-IL-17-PstI) vector components and the SynExpress system of the miRNA Knockout/Delayed feedback for a robust and sustained response against cancers.
Host
Mouse
Target
MUC16
Clone
K8LL7
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
mScarlet
Promoter
CMV
Effector Gene
IL-17
Insertion Sites
PstI
Gene Modification
Knockout
Modification Domain
miRNA
Carrier Type
HBV
Transformation Accuracy
0.96
Cell Culture
Suspension Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.